Clinical Trial Update: Medtronic Market-Released DF4 Lead Imaging

View source ↗

Summary

This document reports a completed clinical trial update for Medtronic's market-released DF4 lead imaging in cardiac rhythm management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachycardia

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Tachycardia | Status: COMPLETED